Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sasol Limited (SOL.JO)
Johannesburg, ZA
Sasol Limited, an integrated chemical and energy corporation founded in 1950 and headquartered in Johannesburg, South Africa, manages its global operations through distinct segments: Mining, Gas, Fuels, and Chemicals (divided across Africa, the Americas, and Eurasia). The company's core activities encompass running coal mines and developing and overseeing upstream oil and gas exploration and production ventures in Mozambique, South Africa, Canada, and Gabon. Sasol is a key supplier of liquid fuels, pipeline gas, and electricity to various markets, and it is actively engaged in the development and deployment of international gas-to-liquids processing technologies. In the chemical sector, Sasol manufactures and distributes a diverse array of products, including polyethylene, polypropylene, polyvinyl chloride, various ketones, alcohols, acrylates, phenolics, ammonium nitrate-based compounds, sulphur dioxide, and specialized mining reagents. These chemicals are integral to numerous applications across industries such as aerosols, cosmetics, fragrances, packaging, paints, adhesives, pharmaceuticals, plastics, mining, pulp and paper, steel, textiles, water purification, agricultural fertilizers, and general chemical manufacturing. Furthermore, the company trades in both commodity and specialty chemicals, encompassing organic and inorganic substances, waxes, phenolic compounds, carbon products, ammonia, and specific industrial gases, while also offering engineering services.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.61% | -3.89% | -12.46% | +38.57% | +80.92% | +89.60% | +142.59% | -12.84% | -10.08% | -57.79% | +310.08% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | -1 |
| Hold | 6 | 0 |
| Sell | 1 | +1 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-9.5% Q4'25: -10.2% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%+115.1% ★ Q4'25: -97.3% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+3.6% Q4'25: +0.7% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%+8.7% Q4'25: +15.1% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%+5.9% ★ Q4'25: +18.4% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%+1.4% Q4'25: -8.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.39× Q4'25: 1.25× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 8 Rev. Ana. 7 EPS Ana. |
Jun 2027 8 Rev. Ana. 7 EPS Ana. |
Jun 2028 7 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
185.27B
est: 184.22B (+0.6%)
|
172.94B
est: 172.09B (+0.5%)
|
172.41B
est: 170.19B (+1.3%)
|
181.46B
est: 182.25B (-0.4%)
|
203.58B
est: 200.91B (+1.3%)
|
190.37B
est: 184.60B (+3.1%)
|
201.91B
est: 128.09B (+57.6%)
|
272.75B
est: 253.70B (+7.5%)
|
289.70B
est: 292.36B (-0.9%)
|
275.11B
est: 275.87B (-0.3%)
|
249.10B
est: 246.96B (+0.9%)
|
258.50B
241.83B – 279.35B
+4.7% YoY
|
264.00B
233.59B – 291.25B
+2.1% YoY
|
267.28B
258.44B – 276.11B
+1.2% YoY
|
| EBITDA |
59.33B
est: 24.90B (+138.2%)
|
41.92B
est: 23.26B (+80.2%)
|
48.41B
est: 23.01B (+110.4%)
|
33.87B
est: 24.64B (+37.5%)
|
27.80B
est: 27.16B (+2.3%)
|
-88.52B
est: 24.95B (-454.7%)
|
34.96B
est: 17.32B (+101.9%)
|
72.93B
est: 34.30B (+112.7%)
|
37.50B
est: 39.52B (-5.1%)
|
-10.19B
est: 37.29B (-127.3%)
|
35.62B
est: 33.39B (+6.7%)
|
34.95B
32.69B – 37.76B
+4.7% YoY
|
35.69B
31.58B – 39.37B
+2.1% YoY
|
36.13B
34.94B – 37.33B
+1.2% YoY
|
| EBIT |
47.71B
est: 13.52B (+252.9%)
|
25.90B
est: 12.63B (+105.1%)
|
32.99B
est: 12.49B (+164.2%)
|
19.00B
est: 13.37B (+42.1%)
|
9.83B
est: 14.74B (-33.3%)
|
-111.00B
est: 13.55B (-919.4%)
|
17.32B
est: 9.40B (+84.2%)
|
62.31B
est: 18.62B (+234.6%)
|
23.56B
est: 21.46B (+9.8%)
|
-25.84B
est: 20.25B (-227.6%)
|
21.62B
est: 18.12B (+19.3%)
|
18.97B
17.75B – 20.50B
+4.7% YoY
|
19.37B
17.14B – 21.37B
+2.1% YoY
|
19.62B
18.97B – 20.26B
+1.2% YoY
|
| Net Income |
29.72B
est: 29.42B (+1.0%)
|
13.23B
est: 26.47B (-50.0%)
|
20.37B
est: 22.18B (-8.1%)
|
8.73B
est: 21.35B (-59.1%)
|
3.39B
est: 22.44B (-84.9%)
|
-91.75B
est: 703.41M (-13,144.1%)
|
9.03B
est: 10.36B (-12.8%)
|
38.96B
est: 28.47B (+36.8%)
|
8.80B
est: 32.83B (-73.2%)
|
-44.27B
est: 25.78B (-271.8%)
|
6.77B
est: 19.25B (-64.8%)
|
14.97B
13.75B – 31.16B
-22.2% YoY
|
19.47B
18.24B – 31.59B
+30.1% YoY
|
23.78B
17.15B – 30.14B
+22.1% YoY
|
| SGA |
33.53B
est: 31.42B (+6.7%)
|
36.54B
est: 29.35B (+24.5%)
|
37.04B
est: 29.03B (+27.6%)
|
44.26B
est: 31.09B (+42.4%)
|
40.27B
est: 34.27B (+17.5%)
|
45.26B
est: 31.49B (+43.7%)
|
40.93B
est: 21.85B (+87.4%)
|
41.16B
est: 43.27B (-4.9%)
|
44.06B
est: 49.87B (-11.6%)
|
47.94B
est: 47.05B (+1.9%)
|
43.06B
est: 42.12B (+2.2%)
|
44.09B
41.25B – 47.65B
+4.7% YoY
|
45.03B
39.84B – 49.68B
+2.1% YoY
|
45.59B
44.08B – 47.10B
+1.2% YoY
|
| EPS |
48.71
est: 45.83 (+6.3%)
|
21.66
est: 41.23 (-47.5%)
|
33.36
est: 34.55 (-3.4%)
|
14.26
est: 33.25 (-57.1%)
|
5.46
est: 34.95 (-84.4%)
|
-148.49
est: 1.10 (-13,652.6%)
|
14.57
est: 16.14 (-9.7%)
|
62.34
est: 44.34 (+40.6%)
|
14.00
est: 51.14 (-72.6%)
|
-69.94
est: 39.90 (-275.3%)
|
10.60
est: 29.46 (-64.0%)
|
33.26
21.42 – 48.54
+12.9% YoY
|
37.34
28.41 – 49.21
+12.3% YoY
|
41.37
26.71 – 46.94
+10.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI South Africa ETF EZA | 1.93% | 10.60M | 0.59% |
| 2 | iShares MSCI South Africa UCITS ETF USD IRSA.L | 1.66% | 4.24M | 0.65% |
| 3 | Pictet Emerging Markets Rising Economies ETF RISE | 0.75% | 161.3K | 0.73% |
| 4 | Vident International Equity Strategy ETF VIDI | 0.72% | 2.85M | 0.61% |
| 5 | Pacer Emerging Markets Cash Cows 100 ETF ECOW | 0.67% | 1.42M | 0.70% |
| 6 | Schwab Fundamental Emerging Markets Large Company Index ETF FNDE | 0.60% | 56.12M | 0.39% |
| 7 | Lazard Emerging Markets Opportunities ETF EMKT | 0.55% | 926.2K | 0.74% |
| 8 | iShares Edge MSCI EM Value Factor UCITS ETF EMVL.L | 0.50% | 8.20M | 0.40% |
| 9 | Dimensional - Emerging Markets Value ETF DFEV | 0.29% | 5.79M | 0.46% |
| 10 | WisdomTree Emerging Markets Multifactor Fund EMMF | 0.28% | 490.2K | 0.48% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Simon Baloyi | President, Chief Executive Officer & Executive Director | 26M | male |
| Antje Gerber | Executive Vice President of International Chemicals | 16M | female |
| Christian Herrmann | Executive Vice President of Marketing and Sales, Energy & Chemicals Southern Africa | 16M | female |
| Vuyo Dominic Kahla | Executive Director and Executive Vice President of Commercial & Legal | 14M | male |
| Walt Bruns | Chief Financial Officer & Executive Director | 12M | male |
| Victor Bester | Executive Vice President of Operations & Projects | 11M | male |
| Sarushen Pillay | Executive Vice President of Business Building, Strategy & Technology | 9M | — |
| Tiffany Sydow | Vice President & Investor Relations Officer | — | — |
| Nina Stofberg | Chief Financial Officer of North American Operations | — | female |
| Alex Anderson | Head of Group Media Relations | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SOL.JO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
